nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.11.2010 | Original Article

Reduced dimethylaminoethanol in [¹⁸F]fluoromethylcholine: an important step towards enhanced tumour visualization

verfasst von: Dominique Slaets, Sylvie De Bruyne, Caroline Dumolyn, Lieselotte Moerman, Koen Mertens, Filip De Vos

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

[¹⁸F]Fluoromethylcholine ([¹⁸F]FCho) is a radiotracer generally used for tumour visualization in patients. Due to high levels of dimethylaminoethanol (DMAE) remaining in [¹⁸F]FCho solutions synthesized by currently available methods, tumour visualization might be compromised.

Methods

An improved purification method involving an optimized purification step for reducing the levels of DMAE was conceived. The physiological explanation for the interference of residual DMAE in [¹⁸F]FCho pharmacokinetics was further elaborated in a xenograft mouse model.

Results

The use of a series of polymer solid-phase extraction cartridges (Oasis HLB/WCX), instead of the commonly used combination of tC18 and Accell CM cartridges, reduced DMAE levels from 402.2±49.6 ppm to 3.0±0.5 ppm. Subsequent in vitro tests proved that (1) [¹⁸F]FCho uptake was reduced in the presence of DMAE at concentrations above 0.5 µM and (2) DMAE is a competitive inhibitor of [¹⁸F]FCho transport. In vivo experiments in xenograft mouse models corroborated reduced tumour uptake at DMAE plasma levels of about 2.5 µM as found in patients injected with contaminated [¹⁸F]FCho.

Conclusion

Residual DMAE, even at levels below choline plasma concentrations found during fasting, compromises [¹⁸F]FCho uptake in vivo and care should be taken to avoid its interference in molecular imaging with [¹⁸F]FCho.

Eliyahu G, Kreizman T, Degani H. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer 2007;120:1721–30.CrossRefPubMed

Glunde K, Jacobs MA, Bhujwalla ZM. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 2006;6:821–9.CrossRefPubMed

DeGrado TR, Baldwin SW, Wang SY, et al. Synthesis and evaluation of F-18-labeled choline analogs as oncologic PET tracers. J Nucl Med 2001;42:1805–14.PubMed

Contractor KB, Kenny LM, Stebbing J, et al. [C-11]Choline positron emission tomography in estrogen receptor-positive breast cancer. Clin Cancer Res 2009;15:5503–10.CrossRefPubMed

DeGrado TR, Coleman RE, Wang SY, et al. Synthesis and evaluation of F-18-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 2001;61:110–7.PubMed

Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-C-11]choline. J Nucl Med 1997;38:842–7.PubMed

Yamamoto Y, Nishiyama Y, Kameyama R, et al. Detection of hepatocellular carcinoma using C-11-choline PET: comparison with F-18-FDG PET. J Nucl Med 2008;49:1245–8.CrossRefPubMed

Zheng QH, Gardner TA, Raikwar S, et al. [C-11]Choline as a PET biomarker for assessment of prostate cancer tumor models. Bioorg Med Chem 2004;12:2887–93.CrossRefPubMed

Hara T. F-18-fluorocholine: a new PET tracer. J Nucl Med 2001;42:1815–7.PubMed

10.

Kryza D, Tadino V, Filannino MA, Villeret G, Lemoucheux L. Fully automated [F-18]fluorocholine synthesis in the TracerLab MXFDG Coincidence synthesizer. Nucl Med Biol 2008;35:255–60.CrossRefPubMed

11.

Mintz A, Wang LM, Ponde DE. Comparison of radiolabeled choline and ethanolamine as probe for cancer detection. Cancer Biol Ther 2008;7:742–7.PubMed

12.

Cornford EM, Braun LD, Oldendorf WH. Carrier mediated blood-brain-barrier transport of choline and certain choline analogs. J Neurochem 1978;30:299–308.CrossRefPubMed

13.

Dodia C, Fisher AB, Chander A, Kleinzeller A. Inhibitors of choline transport in alveolar type-II epithelial-cells. Am J Respir Cell Mol Biol 1992;6:426–9.PubMed

14.

Yavin E. Regulation of phospholipid metabolism in differentiating cells from rat brain cerebral hemispheres in culture: ontogenesis of carrier-specific transport of choline and N-methyl-substituted choline analogs. J Neurochem 1980;34:178–83.CrossRefPubMed

15.

Kwee S, Turner H, Lim J, Wakano C, Coel M. Dimethylaminoethanol reduces 18F-fluoroethylcholine uptake in prostate cancer cells (abstract). J Nucl Med 2006;47 Suppl 1:425P.

16.

Iwata R, Pascali C, Bogni A, Furumoto S, Terasaki K, Yanai K. [F-18]Fluoromethyl triflate, a novel and reactive [F-18]fluoromethylating agent: preparation and application to the on-column preparation of [F-18]fluorocholine. Appl Radiat Isot 2002;57:347–52.CrossRefPubMed

17.

Fludeoxyglucose [18F] injection. European Pharmacopoeia. 5 edition, volume 1. Strasbourg, France: European Directorate for the Quality of Medicines; 2004. p. 822–5.

18.

Reischl G, Bieg C, Schmiedl O, Solbach C, Machulla HJ. Highly efficient automated synthesis of [C-11]choline for multi dose utilization. Appl Radiat Isot 2004;60:835–8.CrossRefPubMed

19.

Hara T, Yuasa M. Automated synthesis of [C-11]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 1999;50:531–3.CrossRefPubMed

20.

Zhang JM, Tian JH, Wang WS, Liu BL. A new technique for labeling of [C-11]-choline, a positron-emitting tracer for tumor imaging. J Radioanal Nucl Chem 2006;267:665–8.CrossRef

21.

DeGrado TR. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med 2002;43:92–6.PubMed

22.

Lockman PR, Allen DD. The transport of choline. Drug Dev Ind Pharm 2002;28:749–71.CrossRefPubMed

23.

Michel V, Yuan ZF, Ramsubir S, Bakovic M. Choline transport for phospholipid synthesis. Exp Biol Med 2006;231:490–504.

24.

Wang T, Li JJ, Chen F, et al. Choline transporters in human lung adenocarcinoma: expression and functional implications. Acta Biochim Biophys Sin 2007;39:668–74.CrossRefPubMed

25.

Kouji H, Inazua M, Yamada T, Tajima H, Aoki T, Matsumiya T. Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells. Arch Biochem Biophys 2009;483:90–8.CrossRefPubMed

26.

Koepsell H, Lips K, Volk C. Polyspecific cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007;24:1227–51.CrossRefPubMed

27.

Zeisel SH. Choline: an essential nutrient for humans. Nutrition 2000;16:669–71.CrossRefPubMed

28.

Rosen MA, Jones RM, Yano Y, Budinger TF. Carbon-11 choline: synthesis, purification, and brain uptake inhibition by 2-dimethylaminoethanol. J Nucl Med 1985;26:1424–8.PubMed

Titel: Reduced dimethylaminoethanol in [18F]fluoromethylcholine: an important step towards enhanced tumour visualization
verfasst von: Dominique Slaets
Sylvie De Bruyne
Caroline Dumolyn
Lieselotte Moerman
Koen Mertens
Filip De Vos
Publikationsdatum: 01.11.2010
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2010
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-010-1508-z

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2010

Methodological issues in the evaluation of FDG PET/CT accuracy in pediatric lymphoma

Ultrafast assessment of left ventricular dyssynchrony from nuclear myocardial perfusion imaging on a new high-speed gamma camera

Lymphatic drainage from the treated versus untreated prostate: feasibility of sentinel node biopsy in recurrent cancer

Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson’s disease by 123I-FP-CIT brain SPECT

Radioguided surgery of primary hyperparathyroidism in a population with a high prevalence of thyroid pathology

Erratum to: Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson’s disease by 123I-FP-CIT brain SPECT